Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

BlackRock reported for 9 months of 2023

10/13/23 BLK

UnitedHealth reported for 9 months of 2023

10/13/23 UNH

Sitronics Group will introduce the first charging station for electric cars by the end of 2023

10/13/23 AFKS

Gazprom may take part in the construction of a gas hub in Iran

10/13/23 GAZP

UK regulator approves Microsoft's deal with Activision Blizzard

10/13/23 MSFT

UK regulator approves Microsoft's deal with Activision Blizzard

10/13/23 ATVI

Samolet Plus acquired the real estate agency Megapolis Service

10/13/23 SMLT

Acron's 9 months results increased marketable products output by 1.2%

10/13/23 AKRN

Ozon launched the largest fullfillment center in Khabarovsk

10/13/23 OZON

Astra IPO was at the upper end of the price range

10/13/23 ASTR